HENDERSON REBECCA M 4
4 · IDEXX LABORATORIES INC /DE · Filed May 15, 2019
Insider Transaction Report
Form 4
HENDERSON REBECCA M
Director
Transactions
- Exercise/Conversion
Common Stock
2019-05-13$43.68/sh+8,790$383,947→ 27,486 total - Sale
Common Stock
2019-05-13$241.57/sh−8,790$2,123,422→ 18,696 total - Exercise/Conversion
Non-Qualified Stock Option (right-to-buy)
2019-05-13−8,790→ 0 totalExercise: $43.68Exp: 2023-05-07→ Common Stock (8,790 underlying)
Footnotes (2)
- [F1]Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,395 shares on May 8, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- [F2]Not applicable.